Dr. Shahul Nilar

Dr. Shahul Nilar received his Ph.D. and the Diploma in Chemical Physics from the Quantum Theory Project, University of Florida, USA. His speciality is in the theoretical and computational study of Intermolecular Interactions. He was honoured with the Presidential Recognition award for Outstanding Contribution to the University of Florida. After a post-doctoral fellowship at the University of New Brunswick, Canada, Dr. Nilar joined the Biotechnology Research Institute of the National Science Council of Canada in Montreal where he worked on the theory and application of molecular solvation.

Having worked in the computational chemistry software and pharmaceutical industries, Dr. Nilar has many years of experience in the molecular design of novel drug candidates against anti-viral, neglected and tropical diseases such as Human Immunodeficiency Virus (HIV), Hepatitis-C, Hepatitis-B and Dengue Fever, the last of which was done at the Novartis Institute for Tropical Diseases, Singapore. His current research at Global Blood Therapeutics, California is in the design of novel small molecule therapies in the area of neglected blood disorders such as Sickle Cell Disease and Beta-thalassemia incorporating Artificial Intelligence methods in the workflow. He has over 80 international publications and presentations in peer reviewed scientific journals and conferences, international patents and software copyrights. In addition, he is an Associate Editor of Current Computer Aided Drug Design, Section Editor/Informatics of Combinatorial and High Throughput Screening, a member of the editorial board of Computational and Theoretical Chemistry, Heliyon and a review editor of Frontiers in Chemistry.